Morbidity not increased in rheumatoid arthritis patient with profound lymphopenia following CD4 monoclonal antibody therapy: comment on the article by Isaacs et al - Reply

Geahča maid

• Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia.
  Dahkki: Isaacs, J, et al.
  Almmustuhtton: (2001)
• Morbidity and mortality in rheumatoid arthritis patients with prolonged therapy-induced lymphopenia: twelve-year outcomes.
  Dahkki: Lorenzi, A, et al.
  Almmustuhtton: (2008)
• HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
  Dahkki: Isaacs, J, et al.
  Almmustuhtton: (1992)
• Humanised monoclonal antibody therapy for rheumatoid arthritis.
  Dahkki: Isaacs, J, et al.
  Almmustuhtton: (1992)
• Survival of patients after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
  Dahkki: Isaacs, J, et al.
  Almmustuhtton: (2004)